Market research
75A.F Assura Plc
F EUR Not available
Latest close
As of 02 Nov 2025
Test a moving-average rule with historical data.
Market facts
- Market cap
- Not available
- P/E ratio
- 8.0
- Analyst target
- Not available
- Dividend yield
- 6.5%
- Beta
- 0.6
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Not available
- Industry
- Not available
- ISIN
- GB00BVGBWW93
- Market cap
- Not available
- P/E ratio
- 8.0
- Analyst target
- Not available
- Dividend yield
- 6.5%
- Beta
- 0.6
- MarketCapitalization
- Not available
About
About Assura Plc
Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA indices and has a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's portfolio was valued at £3.1 billion and has a strong track record of growing financial returns and dividends for shareholders. At Assura we BUILD for health and as the first FTSE 250 certified B Corp we are committed to keeping ESG at the heart of our strategy, creating Healthy Environments (E) and Healthy Communities (S) and maintaining a Healthy Business (G). As of September 10, 2025, Assura Plc operates as a subsidiary of Primary Health Properties Plc.
Research context
Assura Plc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
0 comments
Sign in to join the 75A.F discussion.
No comments yet
Start a focused discussion about 75A.F.